BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33740286)

  • 21. Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfecta.
    Kocijan R; Muschitz C; Fratzl-Zelman N; Haschka J; Dimai HP; Trubrich A; Bittighofer C; Resch H
    Skeletal Radiol; 2013 Feb; 42(2):187-94. PubMed ID: 22955449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone Mass, Density, Geometry, and Stress-Strain Index in Adults With Osteogenesis Imperfecta Type I and Their Associations With Physical Activity and Muscle Function Parameters.
    Coussens M; Lapauw B; Verroken C; Goemaere S; De Wandele I; Malfait F; Banica T; Calders P
    J Bone Miner Res; 2022 Dec; 37(12):2456-2465. PubMed ID: 36239015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of TGF-β Increases Bone Volume and Strength in a Mouse Model of Osteogenesis Imperfecta.
    Greene B; Russo RJ; Dwyer S; Malley K; Roberts E; Serrielo J; Piepenhagen P; Cummings S; Ryan S; Zarazinski C; Uppuganti S; Bukanov N; Nyman JS; Cox MK; Liu S; Ibraghimov-Beskrovnaya O; Sabbagh Y
    JBMR Plus; 2021 Sep; 5(9):e10530. PubMed ID: 34532615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta.
    Cardinal M; Tys J; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH
    Bone; 2019 Jul; 124():137-147. PubMed ID: 31051315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender-dependence of bone structure and properties in adult osteogenesis imperfecta murine model.
    Yao X; Carleton SM; Kettle AD; Melander J; Phillips CL; Wang Y
    Ann Biomed Eng; 2013 Jun; 41(6):1139-49. PubMed ID: 23536112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-Lethal Type VIII Osteogenesis Imperfecta Has Elevated Bone Matrix Mineralization.
    Fratzl-Zelman N; Barnes AM; Weis M; Carter E; Hefferan TE; Perino G; Chang W; Smith PA; Roschger P; Klaushofer K; Glorieux FH; Eyre DR; Raggio C; Rauch F; Marini JC
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3516-25. PubMed ID: 27383115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type V osteogenesis imperfecta: a new form of brittle bone disease.
    Glorieux FH; Rauch F; Plotkin H; Ward L; Travers R; Roughley P; Lalic L; Glorieux DF; Fassier F; Bishop NJ
    J Bone Miner Res; 2000 Sep; 15(9):1650-8. PubMed ID: 10976985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII.
    Fratzl-Zelman N; Morello R; Lee B; Rauch F; Glorieux FH; Misof BM; Klaushofer K; Roschger P
    Bone; 2010 Mar; 46(3):820-6. PubMed ID: 19895918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human dentin characteristics of patients with osteogenesis imperfecta: insights into collagen-based biomaterials.
    Pragnère S; Auregan JC; Bosser C; Linglart A; Bensidhoum M; Hoc T; Nouguier-Lehon C; Chaussain C
    Acta Biomater; 2021 Jan; 119():259-267. PubMed ID: 33122145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone mass and mineralization in osteogenesis imperfecta.
    Fratzl-Zelman N; Misof BM; Klaushofer K; Roschger P
    Wien Med Wochenschr; 2015 Jul; 165(13-14):271-7. PubMed ID: 26208477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homozygosity for CREB3L1 premature stop codon in first case of recessive osteogenesis imperfecta associated with OASIS-deficiency to survive infancy.
    Lindahl K; Åström E; Dragomir A; Symoens S; Coucke P; Larsson S; Paschalis E; Roschger P; Gamsjaeger S; Klaushofer K; Fratzl-Zelman N; Kindmark A
    Bone; 2018 Sep; 114():268-277. PubMed ID: 29936144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4-PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta.
    Duran I; Zieba J; Csukasi F; Martin JH; Wachtell D; Barad M; Dawson B; Fafilek B; Jacobsen CM; Ambrose CG; Cohn DH; Krejci P; Lee BH; Krakow D
    J Bone Miner Res; 2022 Apr; 37(4):675-686. PubMed ID: 34997935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength.
    Kozloff KM; Carden A; Bergwitz C; Forlino A; Uveges TE; Morris MD; Marini JC; Goldstein SA
    J Bone Miner Res; 2004 Apr; 19(4):614-22. PubMed ID: 15005849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta.
    Rauch F; Travers R; Parfitt AM; Glorieux FH
    Bone; 2000 Jun; 26(6):581-9. PubMed ID: 10831929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced Wnt signaling improves bone mass and strength, but not brittleness, in the Col1a1(+/mov13) mouse model of type I Osteogenesis Imperfecta.
    Jacobsen CM; Schwartz MA; Roberts HJ; Lim KE; Spevak L; Boskey AL; Zurakowski D; Robling AG; Warman ML
    Bone; 2016 Sep; 90():127-32. PubMed ID: 27297606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The functional muscle-bone unit in patients with osteogenesis imperfecta type I.
    Veilleux LN; Pouliot-Laforte A; Lemay M; Cheung MS; Glorieux FH; Rauch F
    Bone; 2015 Oct; 79():52-7. PubMed ID: 26004918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased Osteocyte Lacunae Density in the Hypermineralized Bone Matrix of Children with Osteogenesis Imperfecta Type I.
    Mähr M; Blouin S; Behanova M; Misof BM; Glorieux FH; Zwerina J; Rauch F; Hartmann MA; Fratzl-Zelman N
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta.
    Kocijan R; Muschitz C; Haschka J; Hans D; Nia A; Geroldinger A; Ardelt M; Wakolbinger R; Resch H
    Osteoporos Int; 2015 Oct; 26(10):2431-40. PubMed ID: 25956285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanical properties of OI type III bone tissue measured by nanoindentation.
    Fan Z; Smith PA; Eckstein EC; Harris GF
    J Biomed Mater Res A; 2006 Oct; 79(1):71-7. PubMed ID: 16758461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength.
    Sinder BP; White LE; Salemi JD; Ominsky MS; Caird MS; Marini JC; Kozloff KM
    Osteoporos Int; 2014 Aug; 25(8):2097-107. PubMed ID: 24803333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.